doi: 10.1016/j.cmet.2021.06.014 Summary Keywords chronic kidney disease, gut-brain-kidney axis, gut microbiota, metabolites, therapy Citation Zhu J, Fu Y, Olovo CV, Xu J, Wu Q, Wei W, Jiang K and Zheng X (2025) The influence of gut microbiota on the gut-brain-kidney axis and its implications for chronic kidney disease
This presentation (600mg/4ml) is designed for controlled, accurate preparation and dosing by trained healthcare professionals, making it suitable for clinic and pharmacy supply where injectable antioxidant therapy is required
Summary: There is no established contraindication to taking glutathione with fatty liver disease, but NICE guidance does not recommend it, and you should consult your GP or hepatologist before starting any supplement
J.et al (2023)